Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects.
about
Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virusHistone deacetylase inhibitor trichostatin A enhances the antitumor effect of the oncolytic adenovirus H101 on esophageal squamous cell carcinoma in vitro and in vivo.Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo.Rapamycin enhances the activity of oncolytic herpes simplex virus against tumor cells that are resistant to virus replicationRational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector.Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model.Poxviral vectors for cancer immunotherapyStrategies to achieve systemic delivery of therapeutic cells and microbes to tumors.Targeting tumor vasculature through oncolytic virotherapy: recent advances.Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapyIntegrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery.Enhancing biological therapy through conditional regulation of protein stability.Oncolytic viruses in the treatment of cancer: a review of current strategies.Oncolytic and immunotherapeutic vaccinia induces antibody-mediated complement-dependent cancer cell lysis in humans.Oncolytic Virotherapy: A Contest between Apples and Oranges.Theranostic potential of oncolytic vaccinia virus.Oncolytic Viral Therapy for Mesothelioma.Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.Enriching suicide gene bearing tumor cells for an increased bystander effect.Oncolytic viruses: the power of directed evolution.Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies.Passive tumour targeting of polymer-coated adenovirus for cancer gene therapy.Development of a Safe and Effective Vaccinia Virus Oncolytic Vector WR-Δ4 with a Set of Gene Deletions on Several Viral Pathways.
P2860
Q28755816-349611E1-96FB-4267-8C14-E3859E0DE8CAQ30354691-2D29C140-308B-4981-AF70-901ED01301FAQ33613734-EFC54D18-0787-4A5A-97CC-80ECCAA79C51Q35097829-143E7C39-1D43-4DB6-B51C-74EC6D8C1E67Q36088950-036C5085-D192-4C95-B847-119935F1C1A1Q36209165-6B293432-2562-41AD-A0C0-9D6FDD76E077Q36221386-F3335FFD-4FA5-412F-B482-8C571F32CD76Q36350388-B3AA37EB-D7C0-4E3F-B1D8-F7D3AB6BCA3DQ36675446-CBCADEA7-9699-4963-8909-E734FE02E10AQ37031932-16C1F1E0-BE0A-4AE3-B335-7CFF07D1AF13Q37076976-F69E6F2C-F9B2-459D-9CFC-9EB72BEFE7C4Q37115390-73524721-57E4-4827-9DFE-4225A965F621Q37671855-784A03BC-073F-4782-95A3-7C520CA217C3Q38020107-3D81EE58-885E-4C6F-AA93-06F743C98002Q38450392-8224C630-858C-485C-A8B8-56E37F4FA10FQ39230055-5F78EEBF-0FAD-4038-AFC3-BEB529EB33A2Q39628429-9F667983-F069-4C4E-950B-B7AEAC5D2EDFQ40051845-2C313880-790E-44BE-9EC4-071F7E459E60Q40218171-52C4C9D5-90AF-46D8-B32D-4DBE80DD0567Q40223019-42C01CEA-CE84-4090-8AAF-755BB02D48F7Q40630931-E4CFF4C9-781A-403C-BB53-57F190E0F8BBQ45863222-AC4CF8F7-C23E-462D-B634-2D186FB754D1Q45869931-E8B660B5-951D-4D52-BA42-615BDAE4EAE0Q47549076-B0C8EB25-D6F0-48A5-AFC7-E74697B01CAF
P2860
Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects.
@ast
Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects.
@en
type
label
Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects.
@ast
Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects.
@en
prefLabel
Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects.
@ast
Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects.
@en
P2093
P1433
P1476
Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects.
@en
P2093
David Kirn
Stephen H Thorne
Terry Hermiston
P304
P356
10.1053/J.SEMINONCOL.2005.09.007
P577
2005-12-01T00:00:00Z